IL17A and pulmonary emphysema: Overall, our findings shed light on the <i>let-7</i>/RORγt axis with <i>let-7</i> acting as a molecular brake in the generation of Tc17 cells and suggests a novel therapeutic approach for tempering the augmented IL-17-mediated response in emphysema.